Lowenstein Sandler represented RTW Investments in the transaction.Jade Biosciences, Inc. (“Jade”) closed its $80 million financing round. The financing was led by RTW Investments, Fairmount and…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
